| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
To determine whether the changes in insulin-like growth factor-binding proteins (IGFBPs) and IGF-I levels during pregnancy in rats affect the clearance of IGFs from the circulation, we have measured pharmacokinetic parameters and the tissue distribution of radiolabelled IGF-I and LR3IGF-I, a potent analogue which has a markedly reduced affinity of binding to the IGFBPs. Intravenous boluses of radiolabelled growth factors were administered to catheterized virgin and age-matched pregnant rats on day 18 of gestation when plasma IGFBPs, in particular IGFBP-3, are dramatically reduced. IGF-I was cleared more rapidly from plasma in pregnant rats compared with the virgins; metabolic clearance rate (MCR) = 2·88±0·12 (S.E.M.) and 0·90±0·05 ml/min per kg respectively. Although LR3IGF-I was cleared more rapidly than IGF-I from plasma, similar clearance rates for the analogue were obtained in both pregnant and virgin animals, MCR = 9·19±0·15 and 9·84±0·28 ml/min per kg respectively. In virgin rat plasma, labelled IGF-I was mainly associated with the 150 kDa complex, whereas in pregnant rat plasma IGF-I was predominantly associated with lower Mr IGFBPs (approximately 30–50 kDa). The majority of LR3IGF-I was detected as free peptide. A larger proportion of the tracer was detected as small Mr breakdown products in plasma from rats under conditions of reduced binding to IGFBPs, e.g. during pregnancy or when LR3IGF-I was the labelled tracer, suggesting greater rates of IGF degradation. More LR3IGF-I tracer was detected in kidneys, ovaries and adrenals of virgin rats and in the ovaries and adrenals of pregnant rats, compared with IGF-I tracer. IGF-I radioactivity was greater than LR3IGF-I in caecum, brain, liver and heart in virgin rats and in kidneys, caecum, brain, liver, heart, placenta, fetus and fetal plasma of the pregnant rats. These results show that the reduction in IGFBP during pregnancy dramatically increased the clearance of IGF-I from the circulation towards that obtained with LR3IGF-I. The observation that less LR3IGF-I was detected in placenta, fetus and fetal plasma compared with IGF-I raises the possibility that the ability to bind IGFBPs during pregnancy may enhance IGF uptake by the conceptus.
Journal of Endocrinology (1993) 138, 327–336
This article has been cited by other articles:
|
|
 |
|
  C. A. Shoubridge and L. C. Read Preferential Intestinal Delivery of Long[Arg3] Insulin-Like Growth Factor (LR3IGF-I) over IGF-I in Preweaning and Adult Rats Endocrinology, May 1, 2003; 144(5): 1887 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Shoubridge, C.-B. Steeb, and L. C. Read IGFBP mRNA expression in small intestine of rat during postnatal development Am J Physiol Gastrointest Liver Physiol, December 1, 2001; 281(6): G1378 - G1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dubaquie, D. L. Mortensen, A. Intintoli, D. A. Hogue, G. Nakamura, P. Rancatore, P. Lester, M. D. Sadick, E. Filvaroff, P. J. Fielder, et al. Binding Protein-3-Selective Insulin-Like Growth Factor I Variants: Engineering, Biodistributions, and Clearance Endocrinology, January 1, 2001; 142(1): 165 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Robertson, D. A. Belford, and F. J. Ballard Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E663 - E671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hill and J. M. Pell Regulation of Insulin-Like Growth Factor I (IGF-I) Bioactivity in Vivo: Further Characterization of an IGF-I-Enhancing Antibody Endocrinology, March 1, 1998; 139(3): 1278 - 1287. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
